Matthew Charles Mc Murdo Titan Pharmaceuticals Inc (TTNP) insider trading activity

Matthew Charles Mc Murdo is Director of TITAN PHARMACEUTICALS INC. Currently has a direct ownership of 66,250 shares of TTNP, which is worth approximately $265,000. The most recent transaction as insider was on Oct 25, 2023, when has been sold 16,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.3K

0% 3M change

0% 12M change

Total Value Held $265,000

Matthew Charles McMurdo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 25 2023	BUY Grant, award, or other acquisition	-	16,250 Added 19.7%	66,250 Common Stock
Jul 26 2023	BUY Grant, award, or other acquisition	-	50,000 Added 50.0%	50,000 Common Stock

Also insider at

OPGN

OPGEN INC Healthcare

Director

MINM

MINIM, INC. Technology

Director

MCM